𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Heterochromatin, HP1 and methylation at lysine 9 of histone H3 in animals

✍ Scribed by Ian G. Cowell; Rebecca Aucott; Shantha K. Mahadevaiah; Paul S. Burgoyne; Neville Huskisson; Silvia Bongiorni; Giorgio Prantera; Laura Fanti; Sergio Pimpinelli; Rong Wu; David M. Gilbert; Wei Shi; Reinald Fundele; Harris Morrison; Peter Jeppesen; Prim B. Singh

Publisher
Springer
Year
2002
Tongue
English
Weight
567 KB
Volume
111
Category
Article
ISSN
0009-5915

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Prognostic relevance of global histone H
Prognostic relevance of global histone H3 lysine 4 (H3K4) methylation in renal cell carcinoma
✍ JΓΆrg Ellinger; Philip Kahl; Claudia Mertens; Sebastian Rogenhofer; Stefan Hauser πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 392 KB

## Abstract Epigenetic alterations play an important role in carcinogenesis. Recent studies suggested that global histone modifications are predictors of cancer recurrence in various tumor entities. Our study was performed to evaluate histone H3 lysine 4 mono‐methyl (H3K4me1), ‐di‐methyl (H3K4me2)

Differential dynamics of histone H3 meth
Differential dynamics of histone H3 methylation at positions K4 and K9 in the mouse zygote
✍ Konstantin Lepikhov; JΓΆrn Walter πŸ“‚ Article πŸ“… 2004 πŸ› BioMed Central 🌐 English βš– 623 KB

## Background In the mouse zygote the paternal genome undergoes dramatic structural and epigenetic changes. Chromosomes are decondensed, protamines replaced by histones and DNA is rapidly and actively demethylated. The epigenetic asymmetry between parental genomes remains at least until the 2-cell

Loss of trimethylation at lysine 27 of h
Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers
✍ Yongkun Wei; Weiya Xia; Zhihong Zhang; Jinsong Liu; Huamin Wang; Nazmi V. Adsay; πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 238 KB

## Abstract Methylation of lysine 27 on histone H3 (H3K27) by the EZH2 complex is an epigenetic mark that mediates gene silencing. EZH2 is overexpressed in many cancers and correlates with poor prognosis in both breast and prostate cancers. However, the status of H3K27 methylation and its clinical